1DD-LSD
Chemical compound
From Wikipedia, the free encyclopedia
1DD-LSD, also known as 1-dodecanoyl-LSD or as SYN-L-004, is an acylated derivative of lysergic acid diethylamide (LSD). In animal studies, it produces a weak head-twitch response but with 27x lower potency than LSD itself. It is being researched as a potential slow-onset, long lasting prodrug for LSD which is expected to have reduced psychoactive effects.[1][2]
Other names1-Dodecanoyl-LSD; SYN-L-004
| Clinical data | |
|---|---|
| Other names | 1-Dodecanoyl-LSD; SYN-L-004 |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C32H47N3O2 |
| Molar mass | 505.747 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Use and effects
Interactions
Chemistry
Society and culture
Legal status
Canada
1DD-LSD is not a controlled substance in Canada as of 2025.[3]
United States
1DD-LSD is not an explicitly controlled substance in the United States.[4] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.